HERITAGE: a phase III safety and efficacy trial of the proposed trastuzumab biosimilar Myl-1401O versus herceptin. (February 2017)
- Record Type:
- Journal Article
- Title:
- HERITAGE: a phase III safety and efficacy trial of the proposed trastuzumab biosimilar Myl-1401O versus herceptin. (February 2017)
- Main Title:
- HERITAGE: a phase III safety and efficacy trial of the proposed trastuzumab biosimilar Myl-1401O versus herceptin
- Authors:
- Rugo, H.
Barve, A.
Waller, C.
Bronchud, M.H.
Herson, J.
Yuan, J.
Manikhas, A.
Bondarenko, I.
Mukhametshina, G.
Nemsadze, G.
Parra, J.
Abesamis Tiambeng, M.L.
Baramidze, K.
Akewanlop, C.
Vynnychenko, I.
Sriuranpong, V.
Mamillapalli, G.
Ray, S.
Yanez Ruiz, E.P.
Pennella, E. - Abstract:
- Is Part Of:
- European journal of cancer. Volume 72(2017)Supplement 1
- Journal:
- European journal of cancer
- Issue:
- Volume 72(2017)Supplement 1
- Issue Display:
- Volume 72, Issue 1 (2017)
- Year:
- 2017
- Volume:
- 72
- Issue:
- 1
- Issue Sort Value:
- 2017-0072-0001-0000
- Page Start:
- S41
- Page End:
- Publication Date:
- 2017-02
- Subjects:
- Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S0959-8049(17)30216-2 ↗
- Languages:
- English
- ISSNs:
- 0959-8049
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 98.xml